Original Article | Published:

Epidemiology and Population Health

Incidence of components of metabolic syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk In Communities study

International Journal of Obesity volume 42, pages 295301 (2018) | Download Citation

Abstract

Background:

Some obese adults are not afflicted by the metabolic abnormalities often associated with obesity (the ‘metabolically healthy obese’ (MHO)); however, they may be at increased risk of developing cardiometabolic abnormalities in the future. Little is known about the relative incidence of individual components of metabolic syndrome (MetSyn).

Methods:

We used data from a multicenter, community-based cohort aged 45–64 years at recruitment (the Atherosclerosis Risk In Communities study) to examine the first appearance of any MetSyn component, excluding waist circumference. Body mass index (BMI, kg m−2) and cardiometabolic data were collected at four triennial visits. Our analysis included 3969 adults who were not underweight and free of the components of MetSyn at the initial visit. Participants were classified as metabolically healthy normal weight (MHNW), overweight (MHOW) and MHO at each visit. Adjusted hazard ratios (HR) and 95% confidence intervals were estimated with proportional hazards regression models.

Results:

The relative rate of developing each risk factor was higher among MHO than MHNW, with the strongest association noted for elevated fasting glucose (MHO vs MHNW, HR: 2.33 (1.77, 3.06)). MHO was also positively associated with elevated triglycerides (HR: 1.63 (1.27, 2.09)), low high-density lipoprotein-cholesterol (HR: 1.68 (1.32, 2.13)) and elevated blood pressure (HR: 1.54 (1.26, 1.88)). A similar, but less pronounced pattern was noted among the MHOW vs MHNW.

Conclusions:

We conclude that even among apparently healthy individuals, obesity and overweight are related to more rapid development of at least one cardiometabolic risk factor, and that elevations in blood glucose develop most rapidly.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , . Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579–591.

  2. 2.

    , , , , , et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168: 1617–1624.

  3. 3.

    . Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013; 14: 219–227.

  4. 4.

    , , , , , et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906–2912.

  5. 5.

    , , , , , et al. Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study. PLoS One 2014; 9: e98369.

  6. 6.

    , , . Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.

  7. 7.

    , , . Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study. Obesity (Silver Spring, MD) 2013; 21: 203–209.

  8. 8.

    , , , . Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr 2012; 21: 227–233.

  9. 9.

    , , , , . Predicting the development of the metabolically healthy obese phenotype. Int J Obes (Lond) 2015; 39: 228–234.

  10. 10.

    WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157–163.

  11. 11.

    , , , , , . Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond) 2012; 36: 1187–1194.

  12. 12.

    , , , , , et al. The association of incident hypertension with metabolic health and obesity status: definition of metabolic health does not matter. Clin Endocrinol (Oxf) 2016; 85: 207–215.

  13. 13.

    , , , , , et al. Obesity phenotype and incident hypertension: a prospective community-based cohort study. J Hypertens 2013; 31: 145–151.

  14. 14.

    , , , , , et al. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. J Clin Endocrinol Metab 2015; 100: 934–941.

  15. 15.

    , , , , , et al. Stability and changes in metabolically healthy overweight or obesity and risk of future diabetes: Niigata wellness study. Obesity (Silver Spring, MD) 2014; 22: 2420–2425.

  16. 16.

    , , , , , et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab 2013; 98: 2318–2325.

  17. 17.

    , , , , . Are all metabolically healthy individuals with obesity at the same risk of diabetes onset? Obesity (Silver Spring, MD) 2016; 24: 2615–2623.

  18. 18.

    , , , . Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab 2014; 99: 462–468.

  19. 19.

    , , , , , et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 2015; 36: 551–559.

  20. 20.

    , , , , , . Incidence of metabolic risk factors among healthy obese adults: 20-year follow-up. J Am Coll Cardiol 2015; 66: 871–873.

  21. 21.

    , , , , , et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013; 36: 2388–2394.

  22. 22.

    , , , , , et al. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 2014; 37: 2989–2995.

  23. 23.

    The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687–702.

  24. 24.

    , , , , , et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51–65.

  25. 25.

    , , . A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936–942.

  26. 26.

    , , , , . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.

  27. 27.

    , . Tutorial in biostatistics methods for interval-censored data. Stat Med 1998; 17: 219–238.

  28. 28.

    , . Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol 2015; 44: 324–333.

  29. 29.

    , . A nested approach to evaluating dose-response and trend. Ann Epidemiol 1997; 7: 188–193.

  30. 30.

    , , , , . Body mass index at age 25 and all-cause mortality in whites and African Americans: the Atherosclerosis Risk in Communities study. J Adolesc Health 2012; 50: 221–227.

  31. 31.

    , . Modeling Survival Data: Extending the Cox model. Springer: New York, NY, USA, 2000.

  32. 32.

    . A Package for Survival Analysis in S. 2.38 edn. Available at: 2015.

  33. 33.

    . R. A Language and Environment for Statistical Computing, 3.3.1 edn. R Foundation for Statistical Computing: Vienna, Austria, 2016.

  34. 34.

    , , , , , et al. Racial differences in abdominal depot-specific adiposity in white and African American adults. Am J Clin Nutr 2010; 91: 7–15.

  35. 35.

    , , , , , et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring, MD) 2011; 19: 402–408.

  36. 36.

    , , . Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. Am J Clin Nutr 2013; 97: 480–486.

  37. 37.

    , . Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype. Am J Epidemiol 2015; 182: 742–744.

  38. 38.

    , , . Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004; 30: 569–572.

  39. 39.

    , , , . The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev 2014; 15: 781–790.

  40. 40.

    , , , , , et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971–981.

  41. 41.

    . Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37: 1595–1607.

  42. 42.

    , . Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals. Diabetes Metab 2008; 34: 183–184.

  43. 43.

    , , , , , et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145–4150.

Download references

Acknowledgements

The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). We thank the staff and participants of the ARIC study for their important contributions.

Author information

Affiliations

  1. Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA

    • P T Bradshaw
  2. Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA

    • K R Reynolds
    •  & J Stevens
  3. Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA

    • L E Wagenknecht
  4. Johns Hopkins University School of Medicine, Baltimore, MD, USA

    • C E Ndumele
  5. Department of Nutrition, University of North Carolina, Chapel Hill, NC, USA

    • J Stevens

Authors

  1. Search for P T Bradshaw in:

  2. Search for K R Reynolds in:

  3. Search for L E Wagenknecht in:

  4. Search for C E Ndumele in:

  5. Search for J Stevens in:

Competing interests

The authors declare no conflict of interest.

Corresponding author

Correspondence to P T Bradshaw.

About this article

Publication history

Received

Revised

Accepted

Published

DOI

https://doi.org/10.1038/ijo.2017.249